Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
The present clinical study compares the impact of low- and high-dose parenteral testosterone (T) supplementation on daily GH secretory patterns and serum IGF-I, IGFBP-1, and IGFBP-3 concentrations in healthy older (60-82 yr) and young (20-40 yr) men. To this end, we administered three consecutive weekly injections of randomly ordered saline and either a low (100 mg) or a high (200 mg) dose of testosterone enanthate im; namely, saline (n = 17, young and n = 16, older), a low dose (n = 8 young, n = 8 older) and a high dose (n = 9 young, and n = 8 older) of androgen. To monitor somatotropic-axis responses, blood was sampled every 10 min for 24 h for later chemiluminescence-based assay of serum GH, RIA of serum IGF-I, and immunoradiometric assay of serum IGFBP-1 and IGFBP-3 concentrations. Data were analyzed via a nested analysis of covariance statistical design. At baseline (saline injection), older, compared with young, men maintained: 1) similar serum total T, IGFBP-1, and IGFBP-3 but reduced IGF-I concentrations, namely, mean (+/- SEM) IGF-I 160 plus or minus 15 vs. 280 plus or minus 18 microg/liter, (P < 0.001); 2) reduced GH secretory burst mass (0.68 +/- 0.09 vs. 1.2 +/- 0.20 microg/liter, P = 0.031); 3) more disorderly GH release patterns (approximate entropy 0.501 +/- 0.058 vs. 0.288 +/- 0.021, P < 0.001); and 4) blunted 24-h rhythmic GH output (nyctohemeral amplitude 0.25 +/- 0.05 vs. 0.47 +/- 0.08 microg/liter, P = 0.025). Serum T concentrations (ng/dl) did not differ in the two age groups supplemented with either a low dose [550 +/- 50 (young) and 544 +/- 128 (older)] and high [1320 +/- 92 (young) and 1570 +/- 140 (older)] dose of T. The 100-mg dose of androgen exerted no detectable effect on GH secretion in either age cohort but increased the serum IGF-I concentration in young men by 20% (P = 0.00098). The 200-mg dose of T failed to alter daily GH production in young volunteers but in older men stimulated: 1) a 2.03-fold rise in the mean (24-h) serum GH concentration (P = 0.0053, compared with the response to saline); 2) a 1.20-fold increase in basal (nonpulsatile) GH production (P = 0.039); 3) a 2.15-fold amplification of GH secretory burst mass (P = 0.0020); 4) a 2.17-fold elevation of the Mesor of nyctohemeral GH output (P = 0.025); 5) a 1.79-fold enhancement in GH approximate entropy (P = 0.0003); and 6) a 40% increase in the fasting serum IGF-I concentration (P = 0.000005). Multivariate statistical analysis indicated that following high-dose T administration, the E2 increment significantly predicted the IGF-I increment in both age groups combined (P = 0.003); T dose positively forecast the serum total IGF-I concentration (P = 0.0031); and age and T dose jointly determined serum LH concentrations (P = 0.031). In summary, neither a physiological nor a pharmacological dose of T administered parenterally for 3 wk augments daily GH secretion in eugonadal young men. In contrast, a high dose of aromatizable androgen significantly amplifies 24-h basal, pulsatile, entropic, and nyctohemerally rhythmic GH production and elevates the serum IGF-I concentration in older men. The mechanistic basis for the foregoing age-related distinction in GH/IGF-I axis responsivity to T is not known.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sex steroids increase pulsatile and thereby total GH secretion by augmenting the mass of GH secreted in each burst (3,7,16,17).”
From Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp (2005) · cites this paper as [7]
In the citing paper
“The inference of a stable GH secretory burst-renewal process under E 2 drive would agree with the reported uniformity of GH pulse frequency at different stages of puberty, across the menstrual cycle, and in men and women (3, 7, 17, 57-59).”
From Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp (2005) · cites this paper as [7]
Citations
Cites
Approximate entropy as a measure of system complexity.
Pincus, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2297 · Cited by 5,811 · cited 1×
“nonnegative number that monitors relative pattern consistency in serial data (32, 34, 36, 37).”
BackgroundGiustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Self-citationGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Impaired growth hormone secretion in the adult population: relation to age and adiposity.
Rudman, D., Kutner, M. H., Rogers, C. M., Lubin, M. F., Fleming, G. A., & Bain, R. P. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110164 · Cited by 641
Neuroendocrine Control of Growth Hormone Secretion
Müller, E. E., Locatelli, V., & Cocchi, D. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.511 · Cited by 634
Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis
Urban, R. J., Bodenburg, Y. H., Gilkison, C., Foxworth, J., Coggan, A. R., Wolfe, R. R., & Ferrando, A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.5.e820 · Cited by 608
Veldhuis, J. D., Carlson, M. L., & Johnson, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7686 · Cited by 549
Self-citationVeldhuis, J. D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3209 · Cited by 389
Self-citationVERMEULEN, A. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-221 · Cited by 388
Mauras, N., Hayes, V., Welch, S., Rini, A., Helgeson, K., Dokler, M., Veldhuis, J. D., & Urban, R. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4892 · Cited by 368
Self-citation
Cited by
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
Juul, A. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00038-8 · Cited by 467
Blackman, M. R. (2002) · JAMA · doi:10.1001/jama.288.18.2282 · Cited by 455
Testosterone supplementation therapy for older men: potential benefits and risks
Gruenewald, D. A., & Matsumoto, A. M. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1601-5215.2002.51018.x · Cited by 279
Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., & Bowers, C. Y. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0006 · Cited by 236
Self-citationModulation of growth hormone action by sex steroids
Meinhardt, U. J., & Ho, K. K. Y. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02676.x · Cited by 225
Motivations and Methods for Analyzing Pulsatile Hormone Secretion
Veldhuis, J. D., Keenan, D. M., & Pincus, S. M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0005 · Cited by 223
Self-citationBeckman, B. R., Shimizu, M., Gadberry, B. A., & Cooper, K. A. (2003) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2003.10.013 · Cited by 158
Role of Hormones in the Pathogenesis and Management of Sarcopenia
Kamel, H. K., Maas, D. L., & Duthie, E. H. (2002) · Drugs & Aging · doi:10.2165/00002512-200219110-00004 · Cited by 133
The aging male hypothalamic–pituitary–gonadal axis: Pulsatility and feedback
Veldhuis, J. D., Keenan, D. M., Liu, P. Y., Iranmanesh, A., Takahashi, P. Y., & Nehra, A. X. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.005 · Cited by 102
“Two other investigations reported reduced suppression of LH concentrations in older subjects after i.m. injections of high doses of Te (Gentili et al., 2002; Muta et al., 1981).”
BackgroundSelf-citationVeldhuis, J. D. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.12.005 · Cited by 111
“The relevance of relative Te deprivation in aging men is indicated by the fact that supplementation with Te for 2 wk or 6 mo stimulates GH production in older and hypogonadal individuals, but not in Te-replete young men (Gentili et al., 2002; Muniyappa et al., 2007) (Fig.”
InfluentialSelf-citationTargeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction
Suda, M., Paul, K. H., Tripathi, U., Minamino, T., Tchkonia, T., & Kirkland, J. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae010 · Cited by 99
Zajac, A., Poprzęcki, S., Żebrowska, A., Chalimoniuk, M., & Langfort, J. (2010) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e3181d321ff · Cited by 85
“Evidence from studies using various physiological models demonstrates that testosterone stimulates GH release in men (21,39,47).”
Human GH pulsatility: An ensemble property regulated by age and gender
Veldhuis, P. P., & Bowers, C. Y. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345229 · Cited by 91
Effects of testosterone on body composition of the aging male
Mudali, S. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.01.004 · Cited by 77
Physiological Significance of the Rhythmic Secretion of Hypothalamic and Pituitary Hormones
Gan, E. H., & Quinton, R. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81007-2 · Cited by 77
Redman, L. M., Veldhuis, J. D., Rood, J., Smith, S. R., Williamson, D., Ravussin, E., & for the Pennington CALERIE Team (2010) · Aging Cell · doi:10.1111/j.1474-9726.2009.00530.x · Cited by 61
“Basal GH release, maximal GH secretion, the number of secretory bursts and elimination kinetics (Iranmanesh et al., 1994; Gentili et al., 2002; Veldhuis et al., 2005c) do not appear to be affected by aging.”
BackgroundSelf-citationBondanelli, M., Ambrosio, M. R., Margutti, A., Franceschetti, P., Zatelli, M. C., & degli Uberti, E. C. (2003) · Neuroendocrinology · doi:10.1159/000071310 · Cited by 58
“A recent study in healthy elderly men has demonstrated that short-term supraphysiological T supplementation enhances 24-hour basal, pulsatile and nyctohemerally rhythmic GH production and augments the serum insulin-like growth factor I (IGF-I) concentrations [”
BackgroundBowers, C. Y., Granda, R., Mohan, S., Kuipers, J., Baylink, D., & Veldhuis, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031799 · Cited by 57
Self-citationSerum Sex Hormones, IGF-1, and IGFBP3 Exert a Sexually Dimorphic Effect on Lean Body Mass in Aging
Waters, D. L., Yau, C. L., Montoya, G. D., & Baumgartner, R. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.7.m648 · Cited by 55
Veldhuis, J. D., Frystyk, J., Iranmanesh, A., & Ørskov, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1314 · Cited by 54
“Doses of E2 and Te that are known to decrease and increase total IGF-I concentrations in postmenopausal women and older men, respectively were selected (15, 16).”
BackgroundMethodResultSelf-citationVeldhuis, J. D., Mielke, K. L., Cosma, M., Soares-Welch, C., Paulo, R., Miles, J. M., & Bowers, C. Y. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2108 · Cited by 42
“Healthy older men were studied, because high Te concentrations augment 24-h pulsatile GH secretion in aging but not young individuals (20).”
InfluentialSelf-citationDeterministic construct of amplifying actions of ghrelin on pulsatile growth hormone secretion
Farhy, L. S., & Veldhuis, J. D. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00451.2004 · Cited by 45
“The rate of change of plasma GH concentrations is controlled jointly by the distribution volume, elimination kinetics, and secretion rate of GH (33, 61).”
BackgroundSelf-citation[Physiology of androgens in adult men].
Tostain, J.-B., Rossi, D., & Martin, P. (2004) · PubMed · Cited by 44
Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men
Münzer, T., Rosen, C. J., Harman, S. M., Pabst, K. M., Clair, C. S., Sorkin, J. D., & Blackman, M. R. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00166.2005 · Cited by 40
“However, in a short-term study (23), neither low (100 mg) nor high (200 mg) doses of T augmented GH secretion in eugonadal young men, but the higher dose significantly amplified 24-h basal rhythmic GH production and elevated serum IGF-I concentrations in older men.”
BackgroundVeldhuis, J. D., & Iranmanesh, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0834 · Cited by 36
Self-citationMechanisms of Hypoandrogenemia in Healthy Aging Men
Liu, P. Y., Iranmanesh, A., Nehra, A. X., Keenan, D. M., & Veldhuis, J. D. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.008 · Cited by 36
“Second, two clinical investigations reported less suppression of LH concentrations in older compared with young subjects following intramuscular injection of testosterone [63,64].”
BackgroundSelf-citationVeldhuis, J. D., Keenan, D. M., Mielke, K., Miles, J. M., & Bowers, C. Y. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02001 · Cited by 35
“Thus injections occurred on days 1, 8 and 15. The foregoing androgen-supplementation schedule was chosen because it is known to double 24-h GH secretion and elevate IGF-I concentrations by .30% in older but not younger men ( 5 ).”
BackgroundSelf-citationEstradiol Potentiates Ghrelin-Stimulated Pulsatile Growth Hormone Secretion in Postmenopausal Women
Veldhuis, J. D., Keenan, D. M., Iranmanesh, A., Mielke, K. L., Miles, J. M., & Bowers, C. Y. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0948 · Cited by 35
Self-citation(2003) · Obstetrics and Gynecology · doi:10.1097/00006250-200303000-00032 · Cited by 35
Veldhuis, J. D., Anderson, S. M., Kok, P., Iranmanesh, A., Frystyk, J., Ørskov, H., & Keenan, D. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031482 · Cited by 34
“LH, FSH, and PRL concentrations were quantitated by automated chemiluminescence assay (ACS 180, Bayer, Norwood, MA) as described (21).”
MethodSelf-citationLubrano, C., Masi, D., Risi, R., Balena, A., Watanabe, M., Mariani, S., & Gnessi, L. (2020) · Obesity · doi:10.1002/oby.23000 · Cited by 34
“Of note is that visceral fat accumulation in men with obesity has been associated with reduced testosterone levels (7), and it has been suggested that testosterone supplementation may lead to an increased production of GH and IGF1 in healthy elderly men (8); however, little is known regarding the interplay between the…”
BackgroundMünzer, T., Harman, S. M., Sorkin, J. D., & Blackman, M. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1275 · Cited by 34
Hypothalamo-Pituitary Unit, Testis, and Male Accessory Organs
Liu, P. Y., & Veldhuis, J. D. (2019) · Yen and Jaffe's Reproductive Endocrinology · doi:10.1016/b978-0-323-47912-7.00012-3 · Cited by 29
Self-citationVeldhuis, J. D., Reynolds, G. A., Iranmanesh, A., & Bowers, C. Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0620 · Cited by 33
Self-citationRooman, R., Beeck, L. O. D., Martin, M., van Doorn, J., Mohan, S., & Caju, M. V. L. D. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01880 · Cited by 32
“A low or high dose of testosterone did not change serum IGFBP-3 levels in normal men (21, 29, 49 , 50), female to male transsexuals (31) or oophorectomized women (51).”
BackgroundVeldhuis, J. D., & Bowers, C. Y. (2003) · Endocrine · doi:10.1385/endo:22:1:25 · Cited by 32
Self-citationSex-steroid control of the aging somatotropic axis
Veldhuis, J. D., Erickson, D., Iranmanesh, A., Miles, J. M., & Bowers, C. Y. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.006 · Cited by 30
Self-citationAn Ensemble Perspective of Aging-Related Hypoandrogenemia in Men
Liu, P. Y., Takahashi, P. Y., & Veldhuis, J. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-53298-1_16 · Cited by 27
Self-citationVeldhuis, J. D., Anderson, S. M., Iranmanesh, A., & Bowers, C. Y. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1303 · Cited by 27
“The dose was chosen to ensure combined stimulation of GH and IGF-I production, and thereby test the a priori hypothesis of Te-dependent relief of end-product inhibition (5).”
BackgroundMethodInfluentialSelf-citationErickson, D., Keenan, D. M., Mielke, K., Bradford, K., Bowers, C. Y., Miles, J. M., & Veldhuis, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0424 · Cited by 26
Self-citationVeldhuis, J. D., Patrie, J. T., Brill, K. T., Weltman, J. Y., Mueller, E. E., Bowers, C. Y., & Weltman, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0644 · Cited by 25
Self-citationJoint Mechanisms of Impaired Growth-Hormone Pulse Renewal in Aging Men
Veldhuis, J. D., Iranmanesh, A., & Bowers, C. Y. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0336 · Cited by 25
Self-citationMuniyappa, R., Sorkin, J. D., Veldhuis, J. D., Harman, S. M., Münzer, T., Bhasin, S., & Blackman, M. R. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00709.2006 · Cited by 25
“In contrast, in eugonadal men (20–40 yr), neither low- nor high-dose T administration exerted any effect on basal or pulsatile GH secretion, suggesting an age-dependent modulatory effect of T on the GH-IGF-I axis in men (11).”
BackgroundInfluentialSelf-citationDuschek, E. J. J., Gooren, L. J., & Netelenbos, J. C. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.08.011 · Cited by 23
Erickson, D., Keenan, D. M., Farhy, L., Mielke, K., Bowers, C. Y., & Veldhuis, J. D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1621 · Cited by 21
“Sex steroids increase pulsatile and thereby total GH secretion by augmenting the mass of GH secreted in each burst (3, 7, 16, 17).”
BackgroundSelf-citationVeldhuis, J. D., Norman, C., Miles, J. M., & Bowers, C. Y. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2567 · Cited by 20
“The finding that older men do not show comparable facilitation of ghrelin/ GHRP-stimulated GH pulses despite achievement of a high T/E2 milieu may indicate insufficient elevation of E2 in men (2), excessive feedback restraint by the attendant rise in IGF-I (6, 7), and/or a confounding negative effect of T or its metab…”
BackgroundSelf-citationVeldhuis, J. D., Iranmanesh, A., & Keenan, D. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0399 · Cited by 20
Self-citationAn Ensemble Perspective of Aging-Related Hypoandrogenemia in Men
Veldhuis, J. D., Iranmanesh, A., & Keenan, D. M. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-727-7_14 · Cited by 20
Self-citationShort-Term Testosterone Supplementation Relieves Growth Hormone Autonegative Feedback in Men
Veldhuis, J. D., Evans, W. S., Iranmanesh, A., WELTMAN, A. L., & Bowers, C. Y. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031017 · Cited by 18
Self-citationVeldhuis, J. D., Weltman, J. Y., WELTMAN, A. L., Iranmanesh, A., Müller, E. E., & Bowers, C. Y. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0282 · Cited by 17
Self-citationLiu, P. Y., Takahashi, P. Y., Roebuck, P. D., & Veldhuis, J. D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2811 · Cited by 17
“and high physiological amounts of Te or 5 -dihydrotestosterone decrease LH concentrations to a greater (31, 32, 39) or lesser (40, 41) extent in older compared with young men.”
ResultSelf-citationWinters, S. J., Wang, C., & The Fortigel Study Group (2010) · Journal of Andrology · doi:10.2164/jandrol.109.009035 · Cited by 16
Roelfsema, F., Yang, R. J., Takahashi, P. Y., Erickson, D. Z., Bowers, C. Y., & Veldhuis, J. D. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00755 · Cited by 16
Self-citationFrystyk, J. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.001 · Cited by 16
Veldhuis, J. D., Farhy, L. S., WELTMAN, A. L., Kuipers, J., Weltman, J. Y., & Wideman, L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1363 · Cited by 16
Self-citationOrrego, J. J., Dimaraki, E. V., Symons, K., & Barkan, A. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031530 · Cited by 14
“A recent study (32) found that only high doses of im T (200 mg weekly), resulting in supraphysiological androgen concentrations, significantly stimulated basal, pulsatile, and total daily GH secretion and normalized serum IGF-I concentrations in the elderly.”
BackgroundSoares-Welch, C. V., Farhy, L. S., Mielke, K. L., Mahmud, F. H., Miles, J. M., Bowers, C. Y., & Veldhuis, J. D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1365 · Cited by 14
Self-citationDias, J. P., Veldhuis, J. D., Carlson, O. D., Shardell, M. D., Chia, C. W., Melvin, D. L., Egan, J. M., & Basaria, S. S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.025 · Cited by 13
Self-citationRoelfsema, F., Yang, R. J., Takahashi, P. Y., Erickson, D. Z., Bowers, C. Y., & Veldhuis, J. D. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00457 · Cited by 13
“Relative sex-steroid deprivation accentuates GH and IGF-I depletion, because testosterone stimulates GH and IGF-I in older men, hypogonadal males of all ages, and patients undergoing (genotypic female-to-male) gender reassignment [1, 5].”
BackgroundSelf-citationDeterminants of GH-releasing hormone and GH-releasing peptide synergy in men
Veldhuis, J. D., & Bowers, C. Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.91001.2008 · Cited by 12
Self-citationVeldhuis, J. D., Keenan, D. M., Bailey, J. N., Adeniji, A., Miles, J. M., Paulo, R., Cosma, M., & Soares-Welch, C. V. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1516 · Cited by 12
“Concomitant pharmacological T supplementation in an amount that stimulates GH secretion in older but not young men (15) attenuates IGF-I’s suppression of pulsatile GH secretion and secretory-burst mass, without altering IGF-I’s repression of pulse frequency and basal GH secretion or its stimulation of pulse-renewal re…”
BackgroundMethodSelf-citationVeldhuis, J. D., Erickson, D. Z., Wigham, J. R., Weist, S., Miles, J. M., & Bowers, C. Y. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0298 · Cited by 11
“This schedule of androgen supplementation doubles mean (24-h) GH concentrations and elevates IGF-I concentrations by 35% in older, but not young, men (17).”
BackgroundSelf-citationNorup, P. B., Haahr, M. E., Christiansen, P., Aksglæde, L., Cleemann, L. H., Johannsen, T. H., Juul, A., & Main, K. M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae263 · Cited by 10
Cardona, D. M. G., Cárdenas, O. A. N., & Landázuri, P. (2015) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2015.04.007 · Cited by 10
“LCAT en ng/mL 62,85 ± 46,6 (3,92- 151,3) 30,9 ± 11,5 (9,13-99,5) 0,046 18,58”
InfluentialEndogenous testosterone reduces hepatic lipid accumulation in protein-restricted male rats
Uchida, K., Inoue, K., Hasegawa, Y., Hakuno, F., Takahashi, S., & Takenaka, A. (2020) · Nutrition · doi:10.1016/j.nut.2020.111130 · Cited by 8
Liu, P. Y., Takahashi, P. Y., Roebuck, P. D., Bailey, J. N., Keenan, D. M., & Veldhuis, J. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0135 · Cited by 8
Self-citationNeuroendocrine facets of human puberty
Veldhuis, J. D. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00058-7 · Cited by 8
Self-citationSex‐specific effects of dietary restriction on physiological variables in Japanese quails
Reda, G. K., Ndunguru, S. F., Csernus, B., Lugata, J. K., Knop, R., Szabó, C., Czeglédi, L., & Lendvai, Á. Z. (2024) · Ecology and Evolution · doi:10.1002/ece3.11405 · Cited by 6
“While testosterone is reported to increase growth hormone secretion, thereby upregulating hepatic IGF-1 production in humans (Gentili et al., 2002; Gibney et al., 2005 ) and in lizard species with higher male size (Cox et al., 2017 ), the mechanism of action of testos - terone on sexually dimorphic…”
BackgroundMakimura, H., Stanley, T. L., Sun, N., Connelly, J. M., Hemphill, L., & Grinspoon, S. K. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03859.x · Cited by 6
Veldhuis, J. D., & Keenan, D. M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0414 · Cited by 6
“Insulin-like growth factor binding protein (IGFBP)1, IGFBP3, and total IGF1 concentrations were measured by IRMA (Diagnostic Systems Laboratories, Webster, TX, USA) ( 20 , 21).”
MethodInfluentialSelf-citationVeldhuis, J. D., Keenan, D. M., Bailey, J. N., Miles, J. M., & Bowers, C. Y. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0270 · Cited by 6
Self-citationThe Hypothalamo-Pituitary Unit, Testes, and Male Accessory Organs
Liu, P. Y., & Veldhuis, J. D. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00012-7 · Cited by 6
Self-citationSoares-Welch, C. V., Mielke, K. L., Bowers, C. Y., & Veldhuis, J. D. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02294.x · Cited by 6
Self-citationSchurgin, S., Dolan, S. E., Perlstein, A., Sullivan, M. P., Aliabadi, N., & Grinspoon, S. K. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032112 · Cited by 6
Differential pulsatile secretagogue control of GH secretion in healthy men
Norman, C., Miles, J., Bowers, C. Y., & Veldhuis, J. D. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00069.2013 · Cited by 5
Self-citationThe Hypothalamo-Pituitary Unit, Testis, and Male Accessory Organs
Liu, P. Y., & Veldhuis, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00013-5 · Cited by 5
Self-citationPaulo, R., Cosma, M., Soares-Welch, C. V., Bailey, J. N., Mielke, K. L., Miles, J. M., Bowers, C. Y., & Veldhuis, J. D. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1388 · Cited by 5
Self-citationJuul, A. (2005) · KARGER eBooks · doi:10.1159/000088406 · Cited by 5
Veldhuis, J. D., & Bowers, C. Y. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00293.2011 · Cited by 4
Self-citationGleeson, H. K., & Shalet, S. M. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03312.x · Cited by 4
Giordano, R. (2012) · The Open Endocrinology Journal · doi:10.2174/1874216501206010049 · Cited by 4
Luteinizing Hormone Suppression Profiles in Men Treated with Exogenous Testosterone
Miranda, E., Schofield, E., Matsushita, K., Katz, D. J., Nelson, C. J., Benfante, N. E., & Mulhall, J. P. (2022) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2022.06.001 · Cited by 4
Arvat, E., Giordano, R., Pellegrino, M., Lanfranco, F., Baldi, M., PICU, A., Bonelli, L., & Ghigo, E. (2006) · Elsevier eBooks · doi:10.1016/b978-012088484-1/50024-0 · Cited by 3
“Although some reports have demonstrated that both endogenous and exogenous gonadal steroids are able to modulate the GHRH/SS interplay and to affect IGF-I synthesis and secretion [33,37,39,57-59], there is no clear evidence supporting the hypothesis that the age-related decline in the function of GH/IGF-I axis is most…”
BackgroundVeldhuis, J. D., & Bowers, C. Y. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2767 · Cited by 2
“IGFBP-1, IGFBP-3, and total IGF-I concentrations were measured by immunoradiometric assay (Diagnostic Systems Laboratories, Webster, TX) (26, 36).”
MethodSelf-citation[Action of androgens on fat distribution and metabolic balance].
Tostain, J.-B., Heim, M., & Rossi, D. (2004) · PubMed · Cited by 2
Ammini, A. C., Somasundaram, S., & Goswami, R. (2017) · Springer eBooks · doi:10.1007/978-981-10-3695-8_16 · Cited by 2
Physiopathologie du déficit androgénique lié à l'âge
Shakespeare, W. (2004) · Cited by 1
Utility of Ultrasensitive Growth Hormone Assays in Assessing Aging-Related Hyposomatotropism
Iranmanesh, A., & Veldhuis, J. D. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.005 · Cited by 1
“Fasting, GH secretagogues, puberty, estrogen, testosterone, and female gender amplify the size of GH pulses [11,37], whereas aging, obesity, hypopituitarism, GH and IGF-I feedback, somatostatin, and octreotide suppress GH secretory-burst mass [31–34,38–41].”
BackgroundSelf-citationLamb, J. F., & Morley, J. E. (2012) · Wiley eBooks · doi:10.1002/9781119952930.ch97
Déficit androgénique lié à l’âge. Que faut-il attendre de l’androgénothérapie?
Kuhn, J., & Thorin-Savouré, A. (2004) · Andrologie · doi:10.1007/bf03034914
[Is there a place for DHEA, GH and melatonin in the management of age-related androgen deficiency?].
Estour, B., Bossu, C., Nicolau, A. B., Rossi, D., & Tostain, J.-B. (2004) · PubMed
Münzer, T., Harman, S. M., Sorkin, J. D., Blackman, M. R., Klinik, G., & Pepper, C. D. (2009)
Male Behaviors IV: Ageing Brain
Sharma, M., & Kumar, A. (2017) · Springer eBooks · doi:10.1007/978-981-10-3695-8_20
Anti-Aging Medicine LiteratureWatch
(2002) · Rejuvenation Research · doi:10.1089/10945450260195658
McKee, A. M., & Morley, J. E. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch82
Gonadotropins and Testicular Function in Aging
Yuen, F., Liu, P. Y., Swerdloff, R. S., & Wang, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95824-0
Cheng, A. (2013) · The Sydney eScholarship Repository (The University of Sydney)
Metadata
- Authors
- Gentili, A., Mulligan, T., Godschalk, M., Clore, J., Patrie, J., Iranmanesh, A., & Veldhuis, J. D.
- Affiliations
- Virginia Commonwealth University (US)
- Hunter Holmes McGuire VA Medical Center (US)
- University of Virginia (US)
- Salem VA Medical Center (US)
- Corresponding author
- Veldhuis, J. D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-02
- Volume
- 87
- Issue
- 2
- Pages
- 825-834
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2153994601
- Semantic Scholar
- 09ab881355bfd9adcd808fceab416ec436a97676
- Cited by
- 98
- References
- 85
- Citations by year
- 2024: 3 · 2022: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 5 · 2015: 1 · 2013: 2 · 2012: 3
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Virginia
- Virginia Commonwealth University
- National Institute on Aging (R01 AG 19695, R01AG019695)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- testosterone supplementation, testosterone enanthate, somatotropic axis, growth hormone secretion, insulin-like growth factor I, IGFBP-1, IGFBP-3, aging, age differences, healthy men, approximate entropy
- MeSH terms
- Aged, Aged, 80 and over, Aging, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Insulin-Like Growth Factor I, Male, Middle Aged, Prospective Studies, Gonadal Steroid Hormones, Testosterone, Time Factors, Insulin-Like Growth Factor Binding Protein 1, Insulin-Like Growth Factor Binding Protein 3, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.